|Bid||5.77 x 1400|
|Ask||6.55 x 900|
|Day's Range||5.56 - 5.95|
|52 Week Range||4.20 - 14.72|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
Insiders who bought US$432k worth of SomaLogic, Inc. ( NASDAQ:SLGC ) stock in the last year have seen some of their...
Company to host conference call today at 4:30 p.m. ETBOULDER, Colo., May 12, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended March 31, 2022. “Our successful first quarter has kickstarted another exciting year for SomaLogic as we continue to apply the power of the human proteome to improve health and disease management,” said Roy Smythe, M.D., SomaLogic’s Chief Executive Officer. “We have already re
The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make...